Pyrazolopyrimidines As Therapeutic Agents

Abstract

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R<SUB>a</SUB>, R<SUB>2</SUB>, and R<SUB>3 </SUB>are defined as described herein.


Claims
IPC Classifications

Download Citation


Sign in to the Lens

Feedback